2021-01-25
Salivary assay, emerging as a non-invasive alternative to blood assay in clinic analysis, holds great promise for early-stage cancer diagnostics with advantages of low cost, easy collection and facile processing. Therefore, point-of-care (POC) detection of tumor markers in the saliva is urgently demanded.
